597 research outputs found
Explainable Multimodal Emotion Reasoning
Multimodal emotion recognition is an active research topic in artificial
intelligence. Its primary objective is to integrate multi-modalities (such as
acoustic, visual, and lexical clues) to identify human emotional states.
Current works generally assume accurate emotion labels for benchmark datasets
and focus on developing more effective architectures. But due to the inherent
subjectivity of emotions, existing datasets often lack high annotation
consistency, resulting in potentially inaccurate labels. Consequently, models
built on these datasets may struggle to meet the demands of practical
applications. To address this issue, it is crucial to enhance the reliability
of emotion annotations. In this paper, we propose a novel task called
``\textbf{Explainable Multimodal Emotion Reasoning (EMER)}''. In contrast to
previous works that primarily focus on predicting emotions, EMER takes a step
further by providing explanations for these predictions. The prediction is
considered correct as long as the reasoning process behind the predicted
emotion is plausible. This paper presents our initial efforts on EMER, where we
introduce a benchmark dataset, establish baseline models, and define evaluation
metrics. Meanwhile, we observe the necessity of integrating multi-faceted
capabilities to deal with EMER. Therefore, we propose the first multimodal
large language model (LLM) in affective computing, called \textbf{AffectGPT}.
We aim to tackle the long-standing challenge of label ambiguity and chart a
path toward more reliable techniques. Furthermore, EMER offers an opportunity
to evaluate the audio-video-text understanding capabilities of recent
multimodal LLM. To facilitate further research, we make the code and data
available at: https://github.com/zeroQiaoba/AffectGPT
Modeling the IPv6 Internet AS-level Topology
To measure the IPv6 internet AS-level topology, a network topology discovery
system, called Dolphin, was developed. By comparing the measurement result of
Dolphin with that of CAIDA's Scamper, it was found that the IPv6 Internet at AS
level, similar to other complex networks, is also scale-free but the exponent
of its degree distribution is 1.2, which is much smaller than that of the IPv4
Internet and most other scale-free networks. In order to explain this feature
of IPv6 Internet we argue that the degree exponent is a measure of uniformity
of the degree distribution. Then, for the purpose on modeling the networks, we
propose a new model based on the two major factors affecting the exponent of
the EBA model. It breaks the lower bound of degree exponent which is 2 for most
models. To verify the validity of this model, both theoretical and experimental
analyses have been carried out. Finally, we demonstrate how this model can be
successfully used to reproduce the topology of the IPv6 Internet.Comment: 15 pages, 5 figure
Influence of ADAM10 Polymorphisms on Plasma Level of Soluble Receptor for Advanced Glycation End Products and The Association With Alzheimer’s Disease Risk
To determine the role of A disintegrin and metalloproteinase 10 (ADAM10) in genetic susceptibility to Alzheimer’s disease (AD) in a representative Chinese sample, we genotyped 362 AD patients and 370 healthy controls for the rs514049A/C and rs653765C/T polymorphisms in the ADAM10 promoter using the SNaPshot technique. We also examined the potential impact of these polymorphisms on the plasma level of soluble receptor for advanced glycation end products (sRAGE), a decoy receptor whose reduction has been associated with a higher risk of AD. Additionally, a meta-analysis was performed using the present study and the largest GWAS from the International Genomics of Alzheimer’s Project (IGAP). No significant differences were found in the distributions of genotypes or alleles between AD patients and control subjects. However, age-at-onset stratification analysis revealed that there were significant differences in the genotypes (P = 0.015) and alleles (P = 0.006) of the rs653765 SNP. Furthermore, patients with the rs653765 CC genotype showed a lower ADAM10 level and a faster cognitive deterioration than those in patients with the CT/TT genotype in late-onset AD (LOAD), and the rs653765 CC polymorphism was able to regulate the production of the ADAM10 substrate sRAGE. In contrast, the rs514049 polymorphism was not statistically associated with AD. In the meta-analysis, we observed that both rs514049 (A allele vs. C allele, P = 0.002) and rs653765 (C allele vs. T allele, P = 0.004) were associated with AD risk. The present study indicated that the rs653765 polymorphism might be associated with the risk and development of LOAD; in particular, the risk genotype, CC, may decrease the expression of ADAM10, influencing the plasma levels of sRAGE, and thus may be correlated with the clinical progression of AD
Detection of a superconducting phase in a two-atom layer of hexagonal Ga film grown on semiconducting GaN(0001)
The recent observation of superconducting state at atomic scale has motivated
the pursuit of exotic condensed phases in two-dimensional (2D) systems. Here we
report on a superconducting phase in two-monolayer crystalline Ga films
epitaxially grown on wide band-gap semiconductor GaN(0001). This phase exhibits
a hexagonal structure and only 0.552 nm in thickness, nevertheless, brings
about a superconducting transition temperature Tc as high as 5.4 K, confirmed
by in situ scanning tunneling spectroscopy, and ex situ electrical
magneto-transport and magnetization measurements. The anisotropy of critical
magnetic field and Berezinski-Kosterlitz-Thouless-like transition are observed,
typical for the 2D superconductivity. Our results demonstrate a novel platform
for exploring atomic-scale 2D superconductor, with great potential for
understanding of the interface superconductivity
Decreased Blood Levels of Oxytocin in Ketamine-Dependent Patients During Early Abstinence
Background: Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is a common drug of abuse worldwide. Existing evidence suggest a disruption of oxytocin system involves in the development of addiction. In this study, we aimed to investigate the role of oxytocin in ketamine addiction by measuring the blood oxytocin levels in ketamine-dependent (KD) patients.Methods: Sixty-five KD patients and 65 controls were enrolled. Fasting plasma levels of oxytocin were determined at baseline and 1 and 2 weeks after ketamine withdrawal. Ketamine use variables, Beck Depression Inventory, Beck Anxiety Inventory (BAI), Visual Analog Scale for craving, and Childhood Trauma Questionnaire-short form were assessed in KD patients.Results: KD patients had significantly lower levels of oxytocin at baseline compared to controls (5.89 ± 2.13 vs. 9.53 ± 4.17 ng/mL, P < 0.001). Oxytocin levels increased after one (6.74 ± 2.63, P < 0.002) and 2 weeks (6.89 ± 2.69, P = 0.01) of withdrawal in KD patient despite the levels were still lower than controls (P = 0.001 and 0.002, respectively). The clinical variables did not correlate with baseline oxytocin levels except BAI scores, which showed a negative correlation with the levels (r = −0.263; P = 0.039).Conclusion: We found a distinctively reduced oxytocin level in KD patients and the level did not normalize after early abstinence. Lower oxytocin might be associated with anxious phenotype of ketamine dependence. These results suggest that oxytocin system dysregulated following chronic ketamine abuse and might provide insight in evaluating the potential therapeutic use of oxytocin for treating ketamine dependence
Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis
<p>Abstract</p> <p>Objective</p> <p>The objective of this survey was to study the association between <it>Helicobacter pylori </it>infection and the severity of coronary atherosclerosis.</p> <p>Methods</p> <p>The study population consisted of 961 consecutive patients (711 males and 250 females) who underwent coronary angiography for suspected or known coronary atherosclerosis. The patients' body mass index, blood pressure, the blood lipid, blood glucose, leukocyte count (10<sup>9</sup>/L), neutrophil count (10<sup>9</sup>/L), and Helicobacter <it>pylori</it>-specific IgG antibodies were performed. Coronary angiograms were scored according to vessel score and Gensini's score.</p> <p>Results</p> <p>A significant association between <it>H. pylori </it>infection and coronary atherosclerosis as well as its severity was not find in this cross section study (<it>p </it>= 0.858). And, the level distribution of vessel score (<it>p </it>= 0.906) and Gensini's score (<it>p </it>= 0.905) were similar in the seropositivity group and seronegativity group of Helicobacter <it>pylori </it>infection. However, the level of fasting high-density lipoprotein cholesterol (mmol/L) (<it>p </it>= 0.013) was significantly lower in the seropositivity group than that in the seronegativity group of Helicobacter <it>pylori </it>infection.</p> <p>Conclusions</p> <p>In conclusion, in the present study, a significantly correlation between Helicobacter <it>pylori </it>seropositivity and angiographically evaluated severity of atherosclerosis was not find. And, the present study showed a good correlation between Helicobacter <it>pylori </it>infection and decreased HDL cholesterol. However, the exact mechanisms need further study.</p
Recommended from our members
Therapeutic Efficacy and Safety of Traditional Chinese Medicine Classic Herbal Formula Longdanxiegan Decoction for Hypertension: A Systematic Review and Meta-Analysis
Background: The traditional Chinese medicine classic herbal formula Longdanxiegan decoction (LDXGD) is widely used for hypertensive patients in China. Objectives: This systematic review and meta-analysis aimed to evaluate the efficacy and safety of LDXGD for hypertension. Methods: PubMed, EMBASE, Cochrane Central Register of Controlled Trials, Chinese Biomedical Literature Database, Chinese Scientific Journal Database, Chinese National Knowledge Infrastructure, and Wanfang Database were searched up to February 7, 2017 for randomized control trials in treating hypertension. Results: Nine trials were identified. Compared with antihypertensive drugs, Longdanxiegan decoction plus antihypertensive drugs (LPAD) significantly improved systolic blood pressure (BP) (n = 138; MD = −4.82 mmHg; 95% CI: −7.89 to −1.76; P = 0.002), diastolic BP (n = 138; MD = −2.42 mmHg; 95% CI: −3.22 to −1.62; P < 0.00001), categorical BP (n = 509; RR: 1.26; 95% CI: 1.17 to 1.36; P < 0.00001), hypertension related symptoms (n = 509; RR: 1.31; 95% CI: 1.15 to 1.49; P < 0.0001), and heart rate (n = 138; MD = −2.40 bpm; 95% CI: −4.23 to −0.56; P = 0.01). Beneficial effects but no statistically significant reduction in total cholesterol (n = 138; MD = −0.11 mmol/l; 95% CI: −0.65 to 0.44; P = 0.71), or triglyceride (n = 138; MD = −0.20 mmol/l; 95% CI: −0.46 to 0.07; P = 0.14) was observed in LPAD. Compared with antihypertensive drugs, LDXGD used alone significantly improved systolic BP, diastolic BP, and hypertension related symptoms. But there was no difference between LDXGD and antihypertensive drugs on categorical BP (n = 120; RR: 1.09; 95% CI: 0.96 to 1.23; P = 0.18). The safety of LDXGD were still unclear. Conclusions: Due to poor methodological quality of the included trials, as well as potential reporting bias, our review found no conclusive evidence for the effectiveness of LDXGD in treating hypertension. The potential beneficial effects and safety of LDXGD should be assessed in future properly designed trials
Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat
AbstractSpinal and bulbar muscular atrophy (SBMA) is an X-linked neuromuscular disease caused by a trinucleotide (CAG) repeat expansion in the androgen receptor gene. Patients with SBMA have weakness, atrophy, and fasciculations in the bulbar and extremity muscles. Individuals with CAG repeat lengths greater than 62 have not previously been reported. We evaluated a 29year old SBMA patient with 68 CAGs who had unusually early onset and findings not seen in others with the disease. Analysis of the androgen receptor gene confirmed the repeat length of 68 CAGs in both peripheral blood and fibroblasts. Evaluation of muscle and sensory function showed deficits typical of SBMA, and in addition the patient had manifestations of autonomic dysfunction and abnormal sexual development. These findings extend the known phenotype associated with SBMA and shed new insight into the effects of the mutated androgen receptor
- …